Caleb Rans

Belimumab in combination with glucocorticoids and azathioprine did not lower the risk for relapse in patients with antineutrophil cytoplasm antibody-associated vasculitis.

Lutikizumab may not improve pain or inflammation in patients with knee osteoarthritis and concomitant synovitis.

Psoriatic arthritis and psoriasis were associated with significant decreases across multiple patient-reported outcomes, including quality of life and work productivity.

Researchers examined the associations of prevalent vertebral fracture identified on vertebral fracture assessment images in routine practice with incident fractures.

Researchers validated the SLE Disease Activity Score with improved sensitivity to change compared with SLE Disease Activity Index.

Bone mineral density measures were significantly greater at 3 years in postmenopausal women with comorbid osteoporosis and rheumatoid arthritis who were given vitamin D and calcium supplementation.

Sarilumab and tocilizumab have shown no clinically relevant differences in safety and tolerability outcomes.

National and international pharmacovigilance registry data pertaining to the use of biologic agents in patients with juvenile idiopathic arthritis have been combined.

One-third of patients with refractory anti-HMGCR antibodies had improved strength or other evidence of improved disease activity after rituximab treatment.

Treatment with lutikizumab did not result in significantly better improvements in hand joint pain.

Investigators identified risk factors for repeat surgical intervention after initial arthrotomy for presumed septic arthritis of the hip.

Incorporating a pharmacist-led telephone intervention into clinical practice improved medication adherence and clinical outcomes in gout.

Disease remission is associated with an improved physical domains of health-related quality of life in patients with systemic lupus erythematosus.

Researchers assessed clinical and laboratory characteristics of nephrolithiasis in gout using computed tomography.

Corticosteroids may increase the percentage of patients without pain and the percentage of patients with normal function of the affected joint at 12 months.

Researchers investigated whether sonographically determined subclinical enthesopathy in patients with moderate to severe psoriasis regressed under therapy with ustekinumab.

Antidrug antibody incidence was higher using drug-tolerant vs original enzyme immunoassays in patients treated with golimumab.

Can a common measurement of bone material strength predict future breaks in postmenopausal women with recent atypical fractures?

Researchers estimated the incidence and prevalence of systemic sclerosis in recent years in the United Kingdom.

C-reactive protein levels may be an effective predictive measure to assess treatment response in patients with ankylosing spondylitis.

Data support the clinical efficacy of low-dose leflunomide combined with prednisone for the treatment of proliferative lupus nephritis.

The use of lateral spine imaging to detect asymptomatic vertebral fractures in older women may improve osteoporosis identification.

Researchers reviewed the accuracy and characteristics of questionnaire-based PsA screening tools.

Functional disability progressed more rapidly in postmenopausal compared with premenopausal women with rheumatoid arthritis.

TNFi therapy failed to prevent the development of joint ankylosis despite a substantial reduction in inflammation with TNFi therapy.

The safety of switching from reference rituximab to the rituximab biosimilar was comparable to continuation of reference rituximab.

Data show an increased prevalence of psoriasis in patients with gout compared with patients without gout.

Mortality rates were higher in patients with systemic connective tissue diseases and primary systemic vasculitides.

Researchers examined the efficacy and safety of tocilizumab in patients with adult-onset Still’s disease.

Long-term treatment of SLE with belimumab with standard of care resulted in sustained benefits in patient fatigue and health-related quality of life.